Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Y. Mouraviev"'
Autor:
M. Kanonirova, A.A. Novikov, E. L. Luchikhina, Aleksandrova En, D.E. Karateev, G. Gridneva, G. Loukina, N. Demidova, Nasonov El, Y. Mouraviev
Publikováno v:
Annals of the Rheumatic Diseases. 75:246.1-246
Background The ongoing REMARCA study (Russian acronym: Russian InvEstigation of MethotrexAte and biologics in eaRly aCtive inflammatory Arthritis) included patients with early and established active RA, who did not use subcutaneous methotrexate (SC M
Autor:
Y. Olyunin, Nasonov El, M. Kanonirova, Y. Mouraviev, E. L. Luchikhina, N. Demidova, Galina Lukina, G. Gridneva, D.E. Karateev
Publikováno v:
Annals of the Rheumatic Diseases. 73:235.2-236
Background According to Treat to Target (T2T) recommendations the primary goal of treatment of patients (pts) with rheumatoid arthritis (RA) is clinical remission. This implies a revision of treatment every 3-6 months with the use of combination ther
Publikováno v:
Annals of the Rheumatic Diseases. 72:A891.3-A892
Background Uremia stipulated by AA-amyloidosis is one of basic lethal causes in rheumatoid arthritis (RA) pts in Russia. Methods RA pts resistant to earlier therapy with chronic renal insufficiency, stipulated by morphologically confirmed AA-amyloido